CERN Cerner Corporation

Cerner Provides Access to De-Identified Patient Data for COVID-19 Research and Vaccine Development

Cerner Provides Access to De-Identified Patient Data for COVID-19 Research and Vaccine Development

Data Analysis Solution Powered by AWS

KANSAS CITY, Mo., April 24, 2020 (GLOBE NEWSWIRE) -- (Nasdaq: CERN), a global health care technology company, is now offering select U.S. health systems and academic research centers complimentary access to critical de-identified COVID-19 patient data to help fight the pandemic. This offering will provide eligible health care researchers free access to Cerner’s COVID-19 data set to support epidemiological studies, clinical trials and medical treatments related to COVID-19, in line with applicable laws and guidelines.

The de-identified patient data secured and stored on Cerner HealtheDataLab™, powered by Amazon Web Services Inc. (AWS), will include COVID-19-related demographics to help track spread and surge, underlying illnesses and chronic conditions, treatments, lab results and clinical complications and outcomes that could help drive important medical decisions. A committee including Cerner associates and industry advisors will review the applications and identify recipients that will benefit from the complimentary offering.

“Cerner believes deeply in the power of clinical data to advance global research,” said Donald Trigg, president, Cerner. “The current COVID-19 pandemic compelled our team to develop a strategy to help leading health systems advance the search for critical solutions. When we ultimately move from crisis response to recovery, I am hopeful it will also demonstrate the promise of a ‘learning heath network’ to accelerate the next generation of discovery.”

Cerner and AWS’ collaboration continues to focus on making health care better for patients and providers. Last year, Cerner leveraging de-identified data to help make early determinations of the cause of return hospitalizations using AWS services.

“This is a pivotal moment in time when having access to the right information at the right time can help save lives,” Shez Partovi, MD, director of Worldwide Business Development for Healthcare, Life Sciences, and Genomics, Amazon Web Services, Inc. “By supporting complimentary access to Cerner HealtheDataLab there is an opportunity to bring health systems, academic medical centers and technology efforts together to securely share information and approaches to better understand, combat and contain COVID-19.”

Prior to COVID-19, Cerner began working with research institutions to help clinicians more easily and efficiently gain health insights and guide care. Last year, Cerner the development of the Cerner Learning Health NetworkSM , piloting the program with Duke Clinical Research Institute. This work helps automate data collection from multiple sources, including the electronic health record (EHR), to rapidly give medical researchers secure and compliant access to important information that has the potential to transform patient care.



“This opportunity with Cerner is an important example of how access to open science benefits the needs of providers, patients and communities,” said Eric Peterson, MD, Duke Clinical Research Institute, strategic adviser, Cerner. “By harnessing the power of these data sets, researchers can quickly, securely and freely answer scientific questions about this pandemic.”

Amid COVID-19, to enhance and introduce and recommendations to support health systems as they fight the pandemic, waive license fees for expansion of hospital beds, establish new dashboards designed to summarize and display trends, among other efforts globally. Cerner has also launched a giving clients access to new and updated offerings. More information on clinical research can be accessed at .

About Cerner

Cerner’s health technologies connect people and information systems in thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit ,  or connect on , , or . Nasdaq: CERN. Health care is too important to stay the same.

Media Contacts:

Cerner

Misti Preston, Director of Public Relations,

EN
24/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cerner Corporation

CERNER sees an upgrade to Slightly Positive due to a better fundamenta...

The general evaluation of CERNER (US), a company active in the Software industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date December 14, 2021, the closing price was USD 77.26 and...

 PRESS RELEASE

Cerner Announces Increased Quarterly Dividend

Cerner Announces Increased Quarterly Dividend Dividend of $0.27 per issued and outstanding share reflects 23% increase KANSAS CITY, Mo., Dec. 10, 2021 (GLOBE NEWSWIRE) --  (NASDAQ: CERN), a global healthcare technology company, today announced that its board of directors declared a cash dividend to stockholders of $0.27 per issued and outstanding share, up 23 percent from the prior quarterly dividend of $0.22. The cash dividend will be payable January 11, 2022, to shareholders of record as of the close of business December 27, 2021. Cerner intends to pay regular quarterly cash dividend...

 PRESS RELEASE

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Offic...

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Officer Experienced Clinical Executive to Lead Patient and Caregiver Experiences KANSAS CITY, Mo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, today announced Nasim Afsar, MD, MBA, MHM, as the company’s first Chief Health Officer, effective January 2022. In this new role, Dr. Afsar will lead Cerner’s more than 1,000 healthcare professionals who provide insight and guidance to product development and improving the lives of patients and caregivers. She will also lead the quality...

 PRESS RELEASE

Cerner Reports Third Quarter 2021 Results

Cerner Reports Third Quarter 2021 Results Delivers Strong Results Across Key MetricsGAAP Operating Margin and Diluted EPS Lower; Adjusted Operating Margin and Adjusted Diluted EPS Both up Sharply vs. Year-Ago QuarterFull-Year Guidance Increased KANSAS CITY, Mo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: CERN) today announced results for the 2021 third quarter that ended September 30, 2021. The third quarter 2021 earnings release can be viewed as well as on the company’s website at . Cerner will host an earnings conference call to provide additional detail on the Company’s results a...

 PRESS RELEASE

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcome...

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcomes Combining decades of healthcare, life sciences and collaborative research to transform the way care is delivered KANSAS CITY, Mo., Oct. 26, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, announces the launch of a new operating unit, SM, that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights. The combined expertise of the Cerner and Kantar Health teams is expected to help accelerate discovery, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch